Medicamen Organics Stock: price and insider trades · India
Medicamen Organics: what insiders have been doing
Medicamen Organics is a listed company. Its directors and officers file their transactions with SEBI (PIT + SAST). Between 18 October 2025 and 18 October 2026, 2 insiders published 2 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
Insider buying of Medicamen Organics has been absent for the past year.
Compared with its exchange (1,985 companies, median 4 filings), a count of 2 filings is below the norm.
Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 2,000,000 sharesEquity sharesPreferential AllotmentSEBI:8bc45bc3cad2c47f27d5d6a320e70c9457c4b29a
- 714,285 sharesEquity sharesPreferential AllotmentSEBI:0c3b8e32e4ae77a97e6b86e8eb4959943dafb752
2 of 2 declarations
About Medicamen Organics
Medicamen Organics is a company listed on the Bombay Stock Exchange, specializing in the manufacture of pharmaceutical products. It focuses on the development of generic drugs and innovative formulations.